Schedule 13G/A Filing by The Vanguard Group for Health Catalyst Inc

This filing is an amendment to a Schedule 13G, indicating a change in ownership for Health Catalyst Inc. The Vanguard Group, a registered investment advisor, holds securities in Health Catalyst Inc. According to the filing, The Vanguard Group, including its subsidiaries and managed accounts, has the right to receive or direct dividends and proceeds from the sale of these securities. However, no single person or entity other than The Vanguard Group has an interest exceeding 5% in the reported securities. The filing also clarifies that due to an internal realignment on January 12, 2026, certain subsidiaries of The Vanguard Group will now report their beneficial ownership separately. This realignment does not alter the investment strategies pursued. The filing asserts that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing the control of the issuer.